Johnson and Johnson 2015 Annual Report Download - page 41

Download and view the complete annual report

Please find page 41 of the 2015 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 112

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112

Cautionary Factors that may Affect Future Results
This Annual Report contains forward-looking statements. Forward-looking statements do not relate strictly to historical or
current facts and anticipate results based on management’s plans that are subject to uncertainty. Forward-looking
statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other
words of similar meaning in conjunction with, among other things, discussions of future operations, financial performance,
the Company’s strategy for growth, product development, regulatory approval, market position and expenditures.
Forward-looking statements are based on current expectations of future events. The Company cannot guarantee that any
forward-looking statement will be accurate, although the Company believes that it has been reasonable in its expectations
and assumptions. Investors should realize that if underlying assumptions prove inaccurate or that known or unknown risks
or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Investors
are therefore cautioned not to place undue reliance on any forward-looking statements. The Company does not undertake
to update any forward-looking statements as a result of new information or future events or developments.
Risks and uncertainties include, but are not limited to: economic factors, such as interest rate and currency exchange rate
fluctuations; competition, including technological advances, new products and patents attained by competitors;
challenges and uncertainties inherent in new product development, including uncertainty of clinical success and obtaining
regulatory approvals; uncertainty of commercial success of new and existing products; challenges to patents; the impact
of patent expirations; the ability of the company to successfully execute strategic plans, including restructuring plans; the
potential that the expected benefits and opportunities related to the restructuring may not be realized or may take longer to
realize than expected; significant adverse litigation or government action, including related to product liability claims;
impact of business combinations and divestitures; market conditions and the possibility that the on-going share
repurchase program may be suspended or discontinued; significant changes in customer relationships or changes in
behavior and spending patterns or financial distress of purchasers of health care products and services; changes to
applicable laws and regulations, including global health care reforms; trends toward health care cost containment;
increased scrutiny of the health care industry by government agencies; financial instability of international economies and
legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; complex global
supply chains with increasing regulatory requirements; product efficacy or safety concerns resulting in product recalls or
regulatory action; disruptions due to natural disasters; and the potential failure to meet obligations in compliance
agreements with government bodies.
A discussion of these and other factors that could cause actual results to differ materially from expectations can be found
in this Report for the fiscal year ended January 3, 2016, including in Exhibit 99. The Company notes these factors as
permitted by the Private Securities Litigation Reform Act of 1995.
Johnson & Johnson 2015 Annual Report •29